Trust Point Inc. raised its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 2.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,124 shares of the company’s stock after purchasing an additional 622 shares during the period. Trust Point Inc.’s holdings in Option Care Health were worth $755,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of OPCH. Harbor Capital Advisors Inc. lifted its holdings in Option Care Health by 317.9% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after purchasing an additional 73,312 shares in the last quarter. Rheos Capital Works Inc. boosted its position in shares of Option Care Health by 9.8% in the first quarter. Rheos Capital Works Inc. now owns 357,600 shares of the company’s stock valued at $11,994,000 after acquiring an additional 32,000 shares during the period. Vanguard Group Inc. grew its stake in Option Care Health by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock valued at $661,207,000 after acquiring an additional 306,853 shares in the last quarter. Comerica Bank increased its holdings in Option Care Health by 6.5% during the 1st quarter. Comerica Bank now owns 760,915 shares of the company’s stock worth $25,521,000 after acquiring an additional 46,639 shares during the period. Finally, Janus Henderson Group PLC lifted its stake in Option Care Health by 182.9% in the 1st quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock worth $7,617,000 after purchasing an additional 146,837 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.
Option Care Health Price Performance
Shares of Option Care Health stock opened at $31.64 on Friday. The firm has a market capitalization of $5.50 billion, a PE ratio of 20.82, a price-to-earnings-growth ratio of 2.21 and a beta of 1.29. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. Option Care Health, Inc. has a 12 month low of $26.11 and a 12 month high of $34.63. The business’s 50-day moving average price is $31.09 and its 200-day moving average price is $30.16.
Analyst Ratings Changes
Several research firms have recently weighed in on OPCH. Barrington Research upped their price target on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “outperform” rating in a report on Thursday, August 1st. JMP Securities lifted their price target on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th.
Check Out Our Latest Stock Report on OPCH
Insiders Place Their Bets
In other news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at approximately $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, CFO Michael H. Shapiro sold 23,217 shares of Option Care Health stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
- Five stocks we like better than Option Care Health
- 3 Healthcare Dividend Stocks to Buy
- Survey Reveals: America’s Most Coveted Businesses in 2024
- What Are the FAANG Stocks and Are They Good Investments?
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Earnings Per Share Calculator: How to Calculate EPS
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.